Directors' Dealings

RNS Number : 2020W

Immupharma PLC

23 July 2009

 



For Immediate Release

23 July 2009

ImmuPharma PLC

Directors' Dealings

Institutions increase stake

ImmuPharma PLC ('ImmuPharma' or the 'Company') (LSE:IMM) announces that a number of existing and new blue-chip institutional investors have purchased shares from Richard Warr and the Trusts of Richard Warr and Dimitri Dimitriou, who are two of ImmuPharma's founders and Directors.  A total of 12.5 million ordinary shares (16.1% of the issued share capital) of 10 pence each in the Company, were placed by Noble & Company Limited at a price of 86 pence per share to institutional investors on 23 July 2009. Panmure Gordon is the NOMAD and Corporate Broker to the Company. 

Following the disposal, the current holdings directly or through Trust are:

	Ordinary Shares Sold	Ordinary Shares Retained	Percentage  of shares in issue
Richard Warr (1)	6,250,000	3,528,968	4.6%
Dimitri Dimitriou (2)	6,250,000	3,528,969	4.6%
Dr Zimmer & Family	0	23,056,602	29.8%

(1)     Ordinary shares of £0.10 held by Louvre Trustees Limited where the Warr family has a beneficial interest and shares held directly by Richard Warr. 

(2)     Ordinary shares of £0.10 held by Louvre Trustees Limited where the Dimitriou family has a beneficial interest. 

Richard Warr, ImmuPharma's Chairman said: 'We are delighted with the support received from our existing investors and the demand from new investors including M&G Investments.  The allocation of these shares further increases ImmuPharma's free float with the aim of improving overall liquidity.'

For further information please contact: 

ImmuPharma PLC	[phone]
Dimitri Dimitriou, Chief Executive Officer
Richard Warr, Chairman
Panmure Gordon	[phone]
Andrew Burnett/ Rakesh Sharma
Noble & Company Limited	[phone]
John Millar
Buchanan Communications	[phone]
Lisa Baderoon
Rebecca Skye Dietrich

More information on the Company can be found at www.immupharma.com 

 

END

 

 

RDSSELFIDSUSEFW